SCHEDULE 13G FOR SYNLOGIC, INC. BY GINKGO BIOWORKS, INC.

Company

SYNLOGIC, INC.

Filed

June 21, 2019

Accession Number

0000904454-19-000517

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →